Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [41] Nephroprotective effect of lipid-lowering therapy in patients after STEMI
    Oleinikov, V.
    Dushina, E.
    Barmenkova, Y.
    Burko, N.
    Kvasova, O.
    EUROPEAN HEART JOURNAL, 2018, 39 : 958 - 958
  • [42] Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients
    Egede, Rasmus
    Jensen, Lisette Okkels
    Hansen, Henrik Steen
    Antonsen, Lisbeth
    Hansen, Knud Norregaard
    Junker, Anders
    Thayssen, Per
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (03) : 376 - 379
  • [43] A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia
    Townsend, Mary L.
    Hollowell, Stephanie B.
    Bhalodia, Jasmin
    Wilson, Kenneth H.
    Kaye, Keith S.
    Johnson, Melissa D.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (12) : 851 - 855
  • [44] Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
    Silverberg, Michael J.
    Leyden, Wendy
    Hurley, Leo
    Go, Alan S.
    Quesenberry, Charles P., Jr.
    Klein, Daniel
    Horberg, Michael A.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (05) : 301 - +
  • [45] Tenofovir plasma concentrations in obese and normal weight HIV-infected patients.
    Foster, Rachel
    Derrick, Caroline
    Rampaul, Marlon
    Cottrell, Mackenzie
    Cuteri, Angelena
    Bookstaver, P. Brandon
    Caulder, Celeste
    Weissman, Sharon
    Aninyei, Isioma
    Justo, Julie Ann
    PHARMACOTHERAPY, 2017, 37 (06): : E56 - E57
  • [46] Impact of Tenofovir on Renal Function in HIV-Infected, Antiretroviral-Naive Patients
    Horberg, Michael
    Tang, Beth
    Towner, William
    Silverberg, Michael
    Bersoff-Matcha, Susan
    Hurley, Leo
    Chang, Joseph
    Blank, Jackie
    Quesenberry, Charles, Jr.
    Klein, Daniel
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (01) : 62 - 69
  • [47] Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir
    García-Benayas, T
    Rendón, AL
    Rodríguez-Novóa, S
    Barrios, A
    Maida, I
    Blanco, F
    Barreiro, P
    Rivas, P
    González-Lahoz, J
    Soriano, V
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) : 333 - 337
  • [48] Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
    Hall, Andrew M.
    Hendry, Bruce M.
    Nitsch, Dorothea
    Connolly, John O.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) : 773 - 780
  • [49] Tenofovir-associated renal toxicity in a cohort of HIV-infected patients in Ghana
    Nartey, Edmund T.
    Tetteh, Raymond A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 581 - 581
  • [50] Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients
    Chen, Ruijun
    Scherzer, Rebecca
    Hsue, Priscilla Y.
    Jotwani, Vasantha
    Estrella, Michelle M.
    Horberg, Michael A.
    Grunfeld, Carl
    Shlipak, Michael G.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):
12345